JPRN-UMIN000027441
Completed
未知
The clinical trial for safety and efficacy of chronic hepatitis therapeutics agent, 3-oxygelmillpropionic acid polymer for pancreatic cancer (Phase 1) - Hepatitis therapeutics agent, 3-oxygelmillpropionic acid polymer for pancreatic cancer (Phase 1)
ConditionsResectable pancreatic cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Resectable pancreatic cancer
- Sponsor
- Osaka University
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)Patients who could not resected curatively.(2\)Patients with active double cancer. (3\)Patients with serious drug hypersensitivity or with a history of drug allergy.(4\)Patients with serious complications.(5\)Patients with jaundice,cirrhosis or with suspected cirrhosis of the liver.(6\)There is a history of chronic hepatitis B, and in the present study drug has already been ingested.(7\)Patients with active infection.(8\)Women who have a possibility of or in the pregnancy,who hope to become pregnant,or who are breast\-feeding. Men who wish to become pregnant partner.(9\)Patients with severe mental disorder.(10\)Other patients whom the physician decided to be unsuitable for safely carrying out the present study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A research study to find the effect of use of ice to prevent ulceration of mouth in patients receiving Chemotherapy and radiotherapy for head and Neck cancerHealth Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynxCTRI/2020/07/026657Tata Memorial Hospital
Completed
Phase 2
Effect of crocin supplementation in treatment of methadone maintenance treatment patientsAddiction.Mental and behavioural disorders due to multiple drug use and use of other psychoactive substancesIRCT20170420033551N4Kashan University of Medical Sciences60
Completed
Not Applicable
The clinical trials for safety and usefulness of chronic hepatitis therapeutics,agent 3-oxygelmillpropionic acid polymer for the advanced and recurrent colorectal cancer of having the existing chemotherapeutic refractory or intolerance.(Phase 1 test)JPRN-UMIN000022129Osaka University Hospital5
Completed
Phase 3
Effect of combined chromium and carnitine supplementation in treatment of women with polycystic ovary syndromeIRCT20170513033941N38Arak University of Medical Sciences60
Completed
Phase 3
Effect of combined chromium and carnitine supplementation in treatment of women with polycystic ovary syndromeIRCT2017090533941N24Vice chancellor for research, Arak University of Medical Sciences60